Related Experiment Videos

Pregnancy suppression by a platelet activating factor antagonist, ONO-6240, in mice

M Ando1, H Suginami, S Matsuura

  • 1Department of Obstetrics and Gynecology, Ehime University School of Medicine, Japan.

Asia-Oceania Journal of Obstetrics and Gynaecology
|June 1, 1990
PubMed

Insights

Embryo-derived platelet activating factor (EDPAF) is crucial for mouse pregnancy. Blocking EDPAF with ONO-6240 impaired implantation and reduced litter size, highlighting its role in establishing pregnancy.

Area of Science:

  • Reproductive biology
  • Developmental biology
  • Pharmacology

Background:

  • Mouse embryos secrete embryo-derived platelet activating factor (EDPAF) during early development.
  • The precise physiological role of EDPAF in pregnancy establishment remains unclear.

Purpose of the Study:

  • To investigate the physiological significance of EDPAF in mouse pregnancy.
  • To determine the role of EDPAF in embryo implantation and development.

Main Methods:

  • Utilized ONO-6240, a specific platelet activating factor (PAF) antagonist.
  • Administered ONO-6240 to maternal mice and assessed effects on litter size and embryo development.
  • Investigated EDPAF's effect on circulating platelet concentrations in vivo.

Main Results:

  • ONO-6240 dose-dependently antagonized EDPAF-induced platelet reduction.
  • Maternal administration of ONO-6240 led to smaller litter sizes.
  • ONO-6240 did not adversely affect in vivo or in vitro embryo development.

Conclusions:

  • EDPAF plays a significant role in establishing pregnancy in mice.
  • EDPAF appears to promote successful embryo implantation, contributing to normal litter size.

Related Concept Videos